Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Karen Zaderej becomes AxoGen's CEO

This article was originally published in Clinica

Executive Summary

Peripheral nerve regeneration specialist AxoGen has promoted Karen Zaderej to CEO. Ms Zaderej, who was previously chief operating officer, helped to develop and launch the company's Avance nerve graft, and the AxoGuard nerve connector and nerve protector. She has worked for Johnson & Johnson subsidiary Ethicon, and also started her own business, Zaderej Medical Consulting. Alachua, Florida-based AxoGen plans to expand into new markets and develop new products to treat peripheral nerve injuries. Ms Zaderej replaces the former CEO, Jamie Grooms, who will remain chairman of the board.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094717

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel